APA (7th ed.) Citation

Marißen, J., Haiß, A., Meyer, C., Rossum, T. V., Bünte, L. M., Frommhold, D., . . . Härtel, C. (2019). Efficacy of bifidobacterium animalis subsp. lactis (BB-12), b. infantis and lactobacillus acidophilus (La-5) probiotics to prevent gut dysbiosis in preterm infants of 28+0-32+6 weeks of gestation: A randomised, placebo-controlled, double-blind, multicentre trial : the PRIMAL clinical study protocol. BMJ open, 9(11), . https://doi.org/10.1136/bmjopen-2019-032617

Chicago Style (17th ed.) Citation

Marißen, Janina, et al. "Efficacy of Bifidobacterium Animalis Subsp. Lactis (BB-12), B. Infantis and Lactobacillus Acidophilus (La-5) Probiotics to Prevent Gut Dysbiosis in Preterm Infants of 28+0-32+6 Weeks of Gestation: A Randomised, Placebo-controlled, Double-blind, Multicentre Trial : The PRIMAL Clinical Study Protocol." BMJ Open 9, no. 11 (2019). https://doi.org/10.1136/bmjopen-2019-032617.

MLA (9th ed.) Citation

Marißen, Janina, et al. "Efficacy of Bifidobacterium Animalis Subsp. Lactis (BB-12), B. Infantis and Lactobacillus Acidophilus (La-5) Probiotics to Prevent Gut Dysbiosis in Preterm Infants of 28+0-32+6 Weeks of Gestation: A Randomised, Placebo-controlled, Double-blind, Multicentre Trial : The PRIMAL Clinical Study Protocol." BMJ Open, vol. 9, no. 11, 2019, https://doi.org/10.1136/bmjopen-2019-032617.